BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9017254)

  • 1. Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level.
    Tanii H; Taniguchi N; Niigawa H; Hosono T; Ikura Y; Sakamoto S; Kudo T; Nishimura T; Takeda M
    Brain Res; 1996 Dec; 743(1-2):263-70. PubMed ID: 9017254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant neuroleptic syndrome after haloperidol administration].
    Gerbershagen MU; Ito WD; Wappler F; Fiege M; Schulte am Esch J
    Anaesthesist; 2001 May; 50(5):329-32. PubMed ID: 11417268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged neuroleptic malignant syndrome after Haloperidol injection].
    Wystub N; Heymel S; Fritzenwanger M; Schulze PC; Pfeifer R
    Med Klin Intensivmed Notfmed; 2018 Apr; 113(3):212-216. PubMed ID: 28752347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome following cardiac surgery: successful treatment with dantrolene.
    Mieno S; Asada K; Horimoto H; Sasaki S
    Eur J Cardiothorac Surg; 2003 Sep; 24(3):458-60. PubMed ID: 12965323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy.
    Tsuchiya N; Morimura E; Hanafusa T; Shinomura T
    Paediatr Anaesth; 2007 Mar; 17(3):281-4. PubMed ID: 17263746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
    Perry PJ; Wilborn CA
    Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report].
    Mishima T; Tsuboi Y; Higuchi MA; Tsugawa J; Obata T; Yamada T
    Brain Nerve; 2011 May; 63(5):503-7. PubMed ID: 21515931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome in a burn patient.
    Still J; Friedman B; Law E; Deppe S; Epperly N; Orlet H
    Burns; 1998 Sep; 24(6):573-5. PubMed ID: 9776099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
    Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
    Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome in a trauma patient.
    Burke C; Fulda GJ; Castellano J
    J Trauma; 1995 Oct; 39(4):796-8. PubMed ID: 7473981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME; Browning LA; Parker D; Saely S
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM; Shifrar KA
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.
    Gönner F; Baumgartner R; Schüpbach D; Merlo MC
    Psychopharmacology (Berl); 1999 Jun; 144(4):416-8. PubMed ID: 10435416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology and therapy of malignant neuroleptic syndrome].
    Weller M; Kornhuber J
    Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome.
    McHugh TP
    J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amisulpride and neuroleptic malignant syndrome.
    Tu MC; Hsiao CC
    Chang Gung Med J; 2011; 34(5):536-40. PubMed ID: 22035899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome, syndrome malin].
    Takahashi A; Todoroki J; Murasaki M
    Nihon Rinsho; 1996 Mar; 54(3):839-44. PubMed ID: 8904246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
    Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F
    Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.